Enterprise Value
-10.16M
Cash
23.18M
Avg Qtr Burn
-8.698M
Short % of Float
6.81%
Insider Ownership
34.83%
Institutional Own.
26.93%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
LUM-201 (Ibutamoren) Details Pediatric growth hormone deficiency | Phase 3 Initiation | |
LUM-201 (Ibutamoren) Details Turner syndrome | Phase 2 Update |